How High-Cost Drug Billing Impacts Oncology Revenue Cycle (2026 Guide)
In oncology, revenue is not driven by visit volume. It is driven by drug billing accuracy. High-cost drugs such as chemotherapy agents and biologics account for the largest portion of oncology reimbursement. This means even a small billing error can result in significant financial loss per claim. That is why leading providers rely on specialized …
How High-Cost Drug Billing Impacts Oncology Revenue Cycle (2026 Guide) Read More »